> top > docs > PMC:7205724 > spans > 21404-21806 > annotations

PMC:7205724 / 21404-21806 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
739 263-267 Gene denotes ACE2 Gene:59272
740 397-401 Gene denotes ACE2 Gene:59272
741 350-351 Gene denotes S Gene:43740568
742 149-150 Gene denotes S Gene:43740568
743 136-137 Gene denotes S Gene:43740568
744 98-99 Gene denotes S Gene:43740568
745 76-77 Gene denotes S Gene:43740568
746 91-97 Species denotes SARS-2 Tax:2697049
747 142-148 Species denotes SARS-2 Tax:2697049

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T158 177-185 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T159 71-75 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T160 91-95 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T161 131-135 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T162 142-146 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T163 345-349 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T253 14-15 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T254 57-59 http://purl.obolibrary.org/obo/CLO_0008922 denotes S2
T255 57-59 http://purl.obolibrary.org/obo/CLO_0050052 denotes S2
T256 257-259 http://purl.obolibrary.org/obo/CLO_0008922 denotes S2
T257 257-259 http://purl.obolibrary.org/obo/CLO_0050052 denotes S2
T258 379-381 http://purl.obolibrary.org/obo/CLO_0008922 denotes S2
T259 379-381 http://purl.obolibrary.org/obo/CLO_0050052 denotes S2

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T168 57-59 Chemical denotes S2 http://purl.obolibrary.org/obo/CHEBI_29387
T169 257-259 Chemical denotes S2 http://purl.obolibrary.org/obo/CHEBI_29387
T170 379-381 Chemical denotes S2 http://purl.obolibrary.org/obo/CHEBI_29387

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T21 296-319 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes neutralizing antibodies http://purl.bioontology.org/ontology/MEDDRA/10058063

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T211 71-75 Species denotes SARS NCBItxid:694009
T212 91-97 Species denotes SARS-2 NCBItxid:2697049
T213 131-135 Species denotes SARS NCBItxid:694009
T214 142-148 Species denotes SARS-2 NCBItxid:2697049
T215 345-349 Species denotes SARS NCBItxid:694009

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T173 0-100 Sentence denotes 47D11 carried a higher affinity for interacting with the S2 subunit of SARS-S than that of SARS-2-S.
T174 101-282 Sentence denotes It is important that for both SARS-S and SARS-2-S, the binding of the 47D11 antibody to the target – the S1B domain – does not block the binding of S1B and S2 to ACE2 receptor [26].
T175 283-402 Sentence denotes By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S2 for binding to ACE2.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
745 76-77 Gene denotes S Gene:43740568
746 91-97 Species denotes SARS-2 Tax:2697049
744 98-99 Gene denotes S Gene:43740568
743 136-137 Gene denotes S Gene:43740568
747 142-148 Species denotes SARS-2 Tax:2697049
742 149-150 Gene denotes S Gene:43740568
739 263-267 Gene denotes ACE2 Gene:59272
741 350-351 Gene denotes S Gene:43740568
740 397-401 Gene denotes ACE2 Gene:59272

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T2070 206-209 Protein denotes S1B https://www.uniprot.org/uniprot/P47835
T2071 249-252 Protein denotes S1B https://www.uniprot.org/uniprot/P47835
T2072 371-374 Protein denotes S1B https://www.uniprot.org/uniprot/P47835

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T22398 0-5 NN denotes 47D11
T15962 6-13 VBD denotes carried
T83196 14-15 DT denotes a
T61532 16-22 JJR denotes higher
T47874 23-31 NN denotes affinity
T77580 32-35 IN denotes for
T95631 36-47 VBG denotes interacting
T94847 48-52 IN denotes with
T20163 53-56 DT denotes the
T18520 57-59 NN denotes S2
T89003 60-67 NN denotes subunit
T41606 68-70 IN denotes of
T4784 71-77 NN denotes SARS-S
T32288 78-82 IN denotes than
T68894 83-87 DT denotes that
T97000 88-90 IN denotes of
T32517 91-100 NN denotes SARS-2-S.
T24633 101-103 PRP denotes It
T45480 104-106 VBZ denotes is
T10954 107-116 JJ denotes important
T96386 117-121 IN denotes that
T80967 122-125 IN denotes for
T24571 126-130 DT denotes both
T18211 131-137 NN denotes SARS-S
T39196 138-141 CC denotes and
T83081 142-150 NN denotes SARS-2-S
T70298 150-151 -COMMA- denotes ,
T91479 152-155 DT denotes the
T56884 156-163 NN denotes binding
T11559 164-166 IN denotes of
T2922 167-170 DT denotes the
T11592 171-176 NN denotes 47D11
T36887 177-185 NN denotes antibody
T46706 186-188 TO denotes to
T40788 189-192 DT denotes the
T37833 193-199 NN denotes target
T37378 200-201 VBZ denotes –
T15003 202-205 DT denotes the
T4372 206-209 NN denotes S1B
T31100 210-216 NN denotes domain
T82065 217-218 NN denotes –
T43926 219-223 VBZ denotes does
T69422 224-227 RB denotes not
T3419 228-233 VB denotes block
T21955 234-237 DT denotes the
T12942 238-245 NN denotes binding
T83444 246-248 IN denotes of
T49120 249-252 NN denotes S1B
T55070 253-256 CC denotes and
T98634 257-259 NN denotes S2
T48321 260-262 TO denotes to
T80580 263-267 NN denotes ACE2
T18877 268-276 NN denotes receptor
T18503 277-278 -LRB- denotes [
T33177 278-280 CD denotes 26
T92006 280-281 -RRB- denotes ]
T53652 283-285 IN denotes By
T58622 286-294 NN denotes contrast
T35381 294-295 -COMMA- denotes ,
T41843 296-308 VBG denotes neutralizing
T81589 309-319 NNS denotes antibodies
T68196 320-324 WDT denotes that
T30816 325-337 RB denotes specifically
T53446 338-344 NN denotes target
T89813 345-351 NN denotes SARS-S
T95236 352-357 MD denotes could
T7888 358-365 VB denotes compete
T34125 366-370 IN denotes with
T82101 371-374 NN denotes S1B
T1902 375-378 CC denotes and
T24277 379-381 NN denotes S2
T37015 382-385 IN denotes for
T86465 386-393 VBG denotes binding
T1893 394-396 TO denotes to
T91196 397-401 NN denotes ACE2
R37108 T22398 T15962 arg1Of 47D11,carried
R43602 T47874 T15962 arg2Of affinity,carried
R3397 T47874 T83196 arg1Of affinity,a
R69683 T47874 T61532 arg1Of affinity,higher
R78190 T47874 T77580 arg1Of affinity,for
R68969 T95631 T77580 arg2Of interacting,for
R15040 T95631 T94847 arg1Of interacting,with
R25517 T89003 T94847 arg2Of subunit,with
R53417 T89003 T20163 arg1Of subunit,the
R3997 T89003 T18520 arg1Of subunit,S2
R34556 T89003 T41606 arg1Of subunit,of
R37706 T4784 T41606 arg2Of SARS-S,of
R45826 T47874 T32288 arg1Of affinity,than
R81151 T68894 T32288 arg2Of that,than
R10947 T68894 T97000 arg1Of that,of
R87567 T32517 T97000 arg2Of SARS-2-S.,of
R92430 T24633 T45480 arg1Of It,is
R27880 T10954 T45480 arg2Of important,is
R16446 T47874 T45480 modOf affinity,is
R5059 T24633 T10954 arg1Of It,important
R77514 T47874 T96386 arg1Of affinity,that
R45591 T37378 T96386 arg2Of –,that
R6871 T96386 T80967 arg1Of that,for
R86711 T39196 T80967 arg2Of and,for
R85187 T39196 T24571 arg1Of and,both
R57766 T18211 T39196 arg1Of SARS-S,and
R60594 T83081 T39196 arg2Of SARS-2-S,and
R15467 T37378 T70298 arg1Of –,","
R5494 T56884 T91479 arg1Of binding,the
R79151 T56884 T11559 arg1Of binding,of
R6992 T36887 T11559 arg2Of antibody,of
R62361 T36887 T2922 arg1Of antibody,the
R48343 T36887 T11592 arg1Of antibody,47D11
R35747 T56884 T46706 arg1Of binding,to
R10371 T37833 T46706 arg2Of target,to
R36916 T37833 T40788 arg1Of target,the
R17566 T56884 T37378 arg1Of binding,–
R23617 T3419 T37378 arg2Of block,–
R26619 T82065 T15003 arg1Of –,the
R64854 T82065 T4372 arg1Of –,S1B
R97129 T82065 T31100 arg1Of –,domain
R47400 T82065 T43926 arg1Of –,does
R34720 T3419 T43926 arg2Of block,does
R55812 T3419 T69422 arg1Of block,not
R51826 T82065 T3419 arg1Of –,block
R99609 T12942 T3419 arg2Of binding,block
R35148 T12942 T21955 arg1Of binding,the
R30150 T12942 T83444 arg1Of binding,of
R36055 T55070 T83444 arg2Of and,of
R9737 T49120 T55070 arg1Of S1B,and
R3528 T98634 T55070 arg2Of S2,and
R55511 T12942 T48321 arg1Of binding,to
R91010 T18877 T48321 arg2Of receptor,to
R37042 T18877 T80580 arg1Of receptor,ACE2
R82088 T18877 T18503 arg1Of receptor,[
R55576 T33177 T18503 arg2Of 26,[
R41077 T92006 T18503 arg3Of ],[
R68866 T41843 T53652 arg1Of neutralizing,By
R80894 T58622 T53652 arg2Of contrast,By
R42535 T41843 T35381 arg1Of neutralizing,","
R99048 T81589 T41843 arg1Of antibodies,neutralizing
R45757 T81589 T68196 arg1Of antibodies,that
R2391 T7888 T30816 arg1Of compete,specifically
R14961 T89813 T53446 arg1Of SARS-S,target
R96775 T89813 T95236 arg1Of SARS-S,could
R6780 T7888 T95236 arg2Of compete,could
R40504 T89813 T7888 arg1Of SARS-S,compete
R84230 T81589 T7888 arg2Of antibodies,compete
R48027 T7888 T34125 arg1Of compete,with
R59163 T1902 T34125 arg2Of and,with
R39175 T82101 T1902 arg1Of S1B,and
R95020 T24277 T1902 arg2Of S2,and
R6420 T1902 T37015 arg1Of and,for
R67300 T86465 T37015 arg2Of binding,for
R53767 T86465 T1893 arg1Of binding,to
R3636 T91196 T1893 arg2Of ACE2,to

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T158 177-185 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T154 71-75 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T155 91-95 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T156 131-135 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T157 142-146 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T158 345-349 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T173 0-100 Sentence denotes 47D11 carried a higher affinity for interacting with the S2 subunit of SARS-S than that of SARS-2-S.
T174 101-282 Sentence denotes It is important that for both SARS-S and SARS-2-S, the binding of the 47D11 antibody to the target – the S1B domain – does not block the binding of S1B and S2 to ACE2 receptor [26].
T175 283-402 Sentence denotes By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S2 for binding to ACE2.